Showing 771-780 of 2819 results for "".
Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.NeuroAdvocacy: Why Lobbying Matters
https://practicalneurology.com/columns/practice-management/neuroadvocacy-why-lobbying-matters/30328/Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.Filling the Gap in Pediatric Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/filling-the-gap-in-pediatric-neurology/30265/The view from an area without pediatric neurologists.The RNA Blood Test for Multiple Sclerosis: A New Tool for Early Disease Identification
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-rna-blood-test-for-multiple-sclerosis-a-new-tool-for-early-disease-identification/30323/Precision Medicine: How Advancements in Imaging, Delivery, and Patient Comfort are Increasing the Relevance of Deep Brain Stimulation
https://practicalneurology.com/diseases-diagnoses/imaging-testing/precision-medicine-how-advancements-in-imaging-delivery-and-patient-comfort-are-increasing-the-relevance-of-deep-brain-stimulation/30382/Early Diagnosis, Effective Patient Partnerships, and Other Keys to Optimizing Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/early-diagnosis-effective-patient-partnerships-and-other-keys-to-optimizing-multiple-sclerosis-therapy/30485/Standardizing imaging protocols and employing strategies to boost adherence can lead to better treatment outcomes.A Practical Evaluation of Migraine Trigger Site Deactivation Surgery
https://practicalneurology.com/diseases-diagnoses/headache-pain/a-practical-evaluation-of-migraine-trigger-site-deactivation/30696/An analysis of the data casts doubt on the purported benefits of MTSDS.PFO in Cryptogenic Stroke Patients
https://practicalneurology.com/diseases-diagnoses/stroke/pfo-in-cryptogenic--stroke-patients/30817/The lead investigator from the REDUCE trial discusses his perspective on how these patients should be approached.Stigma of Alzheimer's Disease Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/stigma-of-alzheimers-disease-dementia/30229/Clinicians can address the challenges of stigma in routine clinical practice.Headache Medicine: A Crossroad of Otolaryngology, Ophthalmology, and Neurology
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-a-crossroad-of-otolaryngology-ophthalmology-and-neurology/30611/Numerous symptoms can suggest both ophthalmological and neurological disorders.